Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10040790 Bicyclic heterocycles as FGFR inhibitors

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Liang Lu0

Yaping Sun0

Chunhong He0

Fenglei Zhang0

Wenqing Yao0

Date of Patent

August 7, 2018

Patent Application Number

15358371

Date Filed

November 22, 2016

Patent Citations Received

US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same

US Patent 11407750 Derivatives of an FGFR inhibitor

0

US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors

0

US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors

0

US Patent 12012409 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 12024517 Salts of an FGFR inhibitor

0

US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent

0

...

Patent Primary Examiner

Patent abstract

The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10040790 Bicyclic heterocycles as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool